Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ayaka
    Junior Member
    • Apr 2014
    • 6

    #1

    Genomic DNA integrity importance in amplicon sequencing

    Hi there, in my lab we are going to be sequencing 16S with Miseq from stool samples and we are currently in the DNA extraction step.

    We are using Qiagen's QiAmp DNA stool mini kit and have performed an additional step of bead beating that gives us twice of the final DNA concentration. The issue is that when we check the integrity we see smear bands.

    How important is if we want to see diversity to start with integral DNA?

    We think is important, since we don´t have a way to control what DNA is being degraded and we might loose 16S of some bacterias, but we have performed RFLP-PCR and the profiles are very similar and wanted to ask for your experience.

    Thanks!
  • Baseless
    Member
    • Feb 2010
    • 31

    #2
    When sampling DNA from stool I'd expect a stromg degree of degradation and thus a high spread of sizes on gel/bioanalyzer. Even if you have DNA from blood and purify, you would rather see a smear in a certain range typical for your purification method than a sharp peak we know from (most) PCR products. What I would question is, if you do your PCR for whatever 16s fragment you intend to sequence - do you get a PCR product of an appropriate size range?

    Comment

    • Ayaka
      Junior Member
      • Apr 2014
      • 6

      #3
      Hi Baseless thank you for answering. We indeed get a PCR product of the appropriate size. A person from a sequencing center told me that as long as the smeared bands are above the size of the PCR product you want to amplify it would be Ok.
      I still think it could cause loss of diversity though, because of the random fragmentation of the DNA, although I guess it might not be such a big deal...

      Comment

      • Baseless
        Member
        • Feb 2010
        • 31

        #4
        And one more thing to consider on the final product: the 16s amplicons are a diverse thing, so they are allowed to differ a bit in size.
        I would not tolerate this from a PCR amplicon for resequencing of a defined region like for deep-coverage SNV validation, but a degree of size range is ok with me on 16s, TCR and BCR variable regions.
        However, never let your guard down on small fragments on adapter dimers, they only lead into trouble.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:13 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Working...